Bioinformatic Analysis of Plasma Apolipoproteins A-I and A-II Revealed Unique Features of A-I/A-II HDL Particles in Human Plasma

被引:19
作者
Kido, Toshimi [1 ]
Kurata, Hideaki [2 ]
Kondo, Kazuo [3 ]
Itakura, Hiroshige [4 ]
Okazaki, Mitsuyo [5 ]
Urata, Takeyoshi [6 ,7 ,9 ]
Yokoyama, Shinji [8 ]
机构
[1] Ochanomizu Univ, Inst Environm Sci Human Life, Bunkyo Ku, Tokyo 1128610, Japan
[2] Jikei Univ, Sch Med, Div Diabet Metab & Endocrinol, Dept Internal Med,Minato Ku, Tokyo 1058461, Japan
[3] Toyo Univ, Dept Food & Nutr Sci, Itakura, Gunma 3740193, Japan
[4] Shinagawa East One Med Clin, Minato Ku, Tokyo 1080075, Japan
[5] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo 1138519, Japan
[6] Int Mibyou Pre Symptomat Med Med Ctr, Ryugasaki, Ibaraki 3010033, Japan
[7] Showa Univ, Dept Pharmacogen, Shinagawa Ku, Tokyo 1428555, Japan
[8] Chubu Univ, Nutr Hlth Sci Res Ctr, Matsumoto Cho, Kasugai, Aichi 4878501, Japan
[9] Showa Univ, Dept Diabet Metab & Endocrinol, Sch Med, Shinagawa Ku, Tokyo 1428666, Japan
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
关键词
HIGH-DENSITY-LIPOPROTEIN; TRANSFER PROTEIN; APOA-I; DEFICIENCY; SUBCLASSES; ACCUMULATION; DISPLACEMENT; INHIBITION; MECHANISM;
D O I
10.1038/srep31532
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Plasma concentration of apoA-I, apoA-II and apoA-II-unassociated apoA-I was analyzed in 314 Japanese subjects (177 males and 137 females), including one (male) homozygote and 37 (20 males and 17 females) heterozygotes of genetic CETP deficiency. ApoA-I unassociated with apoA-II markedly and linearly increased with HDL-cholesterol, while apoA-II increased only very slightly and the ratio of apoAII- associated apoA-I to apoA-II stayed constant at 2 in molar ratio throughout the increase of HDL-cholesterol, among the wild type and heterozygous CETP deficiency. Thus, overall HDL concentration almost exclusively depends on HDL with apoA-I without apoA-II (LpAI) while concentration of HDL containing apoA-I and apoA-II (LpAI: AII) is constant having a fixed molar ratio of 2 : 1 regardless of total HDL and apoA-I concentration. Distribution of apoA-I between LpAI and LpAI: AII is consistent with a model of statistical partitioning regardless of sex and CETP genotype. The analysis also indicated that LpA-I accommodates on average 4 apoA-I molecules and has a clearance rate indistinguishable from LpAI: AII. Independent evidence indicated LpAI: A-II has a diameter 20% smaller than LpAI, consistent with a model having two apoA-I and one apoA-II. The functional contribution of these particles is to be investigated.
引用
收藏
页数:9
相关论文
共 42 条
  • [31] Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma
    Huang, Rong
    Silva, R. A. Gangani D.
    Jerome, W. Gray
    Kontush, Anatol
    Chapman, M. John
    Curtiss, Linda K.
    Hodges, Timothy J.
    Davidson, W. Sean
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2011, 18 (04) : 416 - U44
  • [32] Separation of apolipoprotein A-I from human plasma by on-line two dimensional liquid chromatography
    Pepaj, Milaim
    Lundanes, Elsa
    Greibrokk, Tyge
    JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2007, 30 (13-16) : 1879 - 1894
  • [33] Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism
    Srivastava, RAK
    Srivastava, N
    Averna, M
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (13): : 4272 - 4280
  • [34] Reduction of phosphatidylcholine hydroperoxide by apolipoprotein A-I: purification of the hydroperoxide-reducing proteins from human blood plasma
    Mashima, R
    Yamamoto, Y
    Yoshimura, S
    JOURNAL OF LIPID RESEARCH, 1998, 39 (06) : 1133 - 1140
  • [35] Selective uptake of cholesteryl esters from high-density lipoprotein-derived LpA-I and LpA-I:A-II particles by hepatic cells in culture
    Rinninger, F
    Kaiser, T
    Windler, E
    Greten, H
    Fruchart, JC
    Castro, G
    BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1998, 1393 (2-3): : 277 - 291
  • [36] Identification of an ABCA1-dependent phospholipid-rich plasma membrane apolipoprotein A-I binding site for nascent HDL formation: implications for current models of HDL biogenesis
    Hassan, Houssein Hajj
    Denis, Maxime
    Lee, Dong-Young Donna
    Iatan, Iulia
    Nyholt, Dana
    Ruel, Isabelle
    Krimbou, Larbi
    Genest, Jacques
    JOURNAL OF LIPID RESEARCH, 2007, 48 (11) : 2428 - 2442
  • [37] Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on paraoxonase and platelet-activating factor acetylhydrolase in human plasma and tissue fluid
    Kujiraoka, T
    Hattori, H
    Ito, M
    Nanjee, MN
    Ishihara, M
    Nagano, M
    Iwasaki, T
    Cooke, CJ
    Olszewski, WL
    Stepanova, IP
    Egashira, T
    Miller, NE
    ATHEROSCLEROSIS, 2004, 176 (01) : 57 - 62
  • [38] Cloning and characterization of cDNAs coding for heavy and light chains of a monoclonal antibody (MabA34) specific for human plasma apolipoprotein A-I
    Kwak, JW
    Lee, DI
    Choi, BK
    Cho, WK
    Lee, SH
    Park, YB
    Han, MH
    GENE, 1996, 173 (02) : 257 - 259
  • [39] TANGIER DISEASE - ISOLATION AND CHARACTERIZATION OF LPA-I, LPA-II, LPA-I-A-II AND LPA-IV PARTICLES FROM PLASMA
    DUCHATEAU, P
    RADER, D
    DUVERGER, N
    THERET, N
    DEGEITERE, C
    BREWER, HB
    FRUCHART, JC
    CASTRO, GR
    BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1182 (01) : 30 - 36
  • [40] The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction
    Gibson, C. Michael
    Kerneis, Mathieu
    Yee, Megan K.
    Daaboul, Yazan
    Korjian, Serge
    Mehr, Ali Poyan
    Tricoci, Pierluigi
    Alexander, John H.
    Kastelein, John J. P.
    Mehran, Roxana
    Bode, Christoph
    Lewis, Basil S.
    Mehta, Ravindra
    Duffy, Danielle
    Feaster, John
    Halabi, Majdi
    Angiolillo, Dominick J.
    Duerschmied, Daniel
    Ophuis, Ton Oude
    Merkely, Bela
    AMERICAN HEART JOURNAL, 2019, 208 : 81 - 90